{"id":134475,"name":"NATIONAL HEALTH COUNCIL","slug":"national-health-council","state":"DC","country":"United States of America","description":"","totalSpending":712076,"filings":33,"yearlySpending":[{"year":2018,"income":13375},{"year":2019,"income":75000},{"year":2020,"income":80000},{"year":2021,"income":85000},{"year":2022,"income":110000},{"year":2023,"income":105000},{"year":2024,"income":145000},{"year":2025,"income":98701}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["NATIONAL HEALTH COUNCIL"],"lobbyists":["ERIC GASCHO","JENNIFER DEXTER","KIMBERLY BEER"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Office of Management & Budget (OMB)"],"sampleDescriptions":["Bipartisan Healthcare Stabilization Act\n-General support\n\nAssociation Health Plan Proposed Rule\n-Opposition\n\nShort-Term Limited Duration Insurance Plan Proposed Rule\n-Opposition\n\nHR 2212/S 974 - Creat","Association Health Plan Proposed Rule\n-Opposition\n\nShort-Term Limited Duration Insurance Plan Proposed Rule\n-Opposition\n\nHR 2212/S 974 - Creating and Restoring Equal Access to Equivalent Samples (CREA","HR 2430/S 934 - FDA Reauthorization Act (implementation)\n-Patient Engagement\n\nS. 3000 - Patient Advocacy Transparency Act\n-Refinement\n\nHHS Blueprint - American Patients First\n-General support and refi","HHS Blueprint - American Patients First\n-General opposition to and refinement of HHS memorandum to Medicare Advantage insurers, allowing step therapy for Part B drugs.\n\nAffordable Care Act Stabilizati","PCORI Reauthorization\n-Support\n\nHR 965 - CREATES Act\n-General Support\n\nHR 1884 - Protecting Pre-Existing Conditions and Making Health Care More Affordable Act\n-Support\n\nPatient Affordability Value and"]}